Thursday's noteworthy 1,000-point drop is indicative of a disturbing trend. Here's what investors should be aware of as more ...
VANCOUVER, Wash. and NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with ...